An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections.

Link to article at PubMed

Icon for European Review for Medical and Pharmacological Sciences Related Articles

An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections.

Eur Rev Med Pharmacol Sci. 2020 04;24(7):4030-4034

Authors: Ahmad A, Rehman MU, Alkharfy KM

Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new strain that was discovered in 2019 and has not been previously identified in humans. On December 31st 2019 World Health Organization (WHO) was informed of a cluster of cases with pneumonia of unknown origin from Wuhan City, Hubei province of China. The WHO announced in February 2020 that COVID-19 is the official name of the coronavirus diseases. A total of 519,899 confirmed cases with 23,592 deaths linked to this pathogen as on March 27, 2020 have been reported. Due to increasing number of infected people across the continents and huge loss to human life, the WHO has declared the novel COVID-19 outbreak a pandemic. A pandemic is defined as the "worldwide spread" of a new disease. Currently, no COVID-19 specific treatments have been approved by the United States Food and Drug Administration (US-FDA). However, the current treatment options include hydroxychloroquine, tocilizumab, remdesivir, lopinavir-ritonavir (Kaletra®), and nitazoxanide. In recent past, some natural herbal compounds have demonstrated encouraging anti-viral properties. This article attempted to summarize available information on the reported anti-viral activity of some natural products.

PMID: 32329879 [PubMed - indexed for MEDLINE]

Leave a Reply

Your email address will not be published. Required fields are marked *